Sabra Healthcare REIT (SBRA) Stock: Buy, Sell, or Hold?
SBRA - Sabra Healthcare REIT, Inc.
$20.52
-0.31 (-1.49%)
▼
5d:
-1.96%
30d:
+1.63%
90d:
+10.98%
HOLD
MODERATE Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When SBRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SBRA shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SBRA shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$39.43
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$24.49
16.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBRA is currently trading at $20.52, which is considered fair relative to its 30-day fair value range of $20.33 to $20.91. The stock's valuation (Forward PE: 25.3) is in line with its historical norms (26.0). Remarkably, the market is currently pricing in an annual earnings decline of 0.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SBRA is in a strong uptrend. The price is currently testing key support at $20.25. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $22.79 (+11.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SBRA is in a strong uptrend. The price is currently testing key support at $20.25. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $22.79 (+11.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$20.33 -
$20.91
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
70.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($22.79)
- NEUTRAL: Bottoming setup forming (43/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$20.33 -
$20.91
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$20.26
Resistance Level
$21.19
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
25.33
Wall Street Target
$22.79
(+11.0%)
Revenue Growth (YoY)
25.3%
Earnings Growth (YoY)
-5.6%
Profit Margin
7.6%
Valuation Discount vs History
-0.9% cheaper
PE vs Historical
25.3 vs 26.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.9%
(market-implied from PE analysis)
1-Year Target
$20.34
(-1%)
2-Year Target
$20.15
(-2%)
3-Year Target
$19.97
(-3%)
3-Yr Target (if PE normalizes)
(PE: 25→26)
$20.50
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 25.3, Growth: 67.2%)
$69.25
(+238%)
Base:
(SPY PE: 20.2, Growth: 67.2%)
$55.14
(+169%)
Bear:
(PE: 17.1, Growth: 67.2%)
$46.87
(+128%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (32x PE), but valuation improves significantly next year (25x PE) as earnings recover.
Forward PE: 32.15 | Forward EPS (Implied): $0.64
Bull Case
$24.78
(+21%)
Analyst growth 15.0%, PE expands to 33.8
Base Case
$20.52
(0%)
Market implied 0.0%, PE stable at 32.2
Bear Case
$15.70
(-24%)
Severe decline -15.0%, PE contracts to 28.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 25.3 to 26.0
Stabilization Target:
$21.06
(+2.6%)
PE Expansion Potential:
+2.6%
Share & Embed Analysis
Last updated: September 11, 2026 9:02 PM ET
Data refreshes hourly during market hours. Next update: 10:02 PM
Data refreshes hourly during market hours. Next update: 10:02 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated REIT - Healthcare Facilities Stocks
Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VTR
Ventas Inc |
STRONG BUY
20 analysts |
$102 | 57 HOLD |
|
WELL
Welltower Inc |
STRONG BUY
20 analysts |
$262 | 54 HOLD |
|
DOC
Healthpeak Properties Inc |
STRONG BUY
20 analysts |
$23 | 41 HOLD |
|
STRW
Strawberry Fields REIT L… |
STRONG BUY
7 analysts |
$16 | 60 HOLD |
|
OHI
Omega Healthcare Investo… |
HOLD
16 analysts |
$52 | 61 BUY |
